Mental Disorders

Early Brain Ageing Linked to the Gut–Brain Axis

Higher functional-connectivity-derived brain age deviation was consistently associated with poorer cognitive performance—particularly working memory and executive function—and greater depressive symptoms in young and mid-life adults, while also showing links to gut microbial and metabolic signatures. In a discovery cohort of 674 participants, with replication in a cohort of 444 and an independent cohort of 344 participants, researchers used resting-state fMRI and whole-brain functional connectivity to derive a brain ageing index (BAI), defined as the difference between predicted and chronological age after correcting for age-related bias. Predicted brain age correlated moderately with chronological age across cohorts (r=0.50–0.59), and higher BAI was reproducibly associated with altered connectivity involving the posterior cingulate/precuneus and medial frontal regions, as well as poorer cognition and more depressive symptoms. In the independent cohort, integrated stool metagenomic and metabolomic analyses identified microbial taxa and metabolites—including ceramides, 24-hydroxycholesterol, dicarboxylic acids, and estetrol—associated with BAI. Pathway analyses suggested potential involvement of neuroimmune, vascular, synaptic, and mitochondrial processes. These findings suggest that functional brain connectivity can capture individual differences in early brain ageing and may provide a window into biological pathways linking the brain and gut to brain health. Source: https://www.thelancet.com/

hyangiu

Recent Posts

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

20 hours ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

20 hours ago

Stopping Statins Noninferior to Continuing Them in Older Adults without Known CVD

Among older adults with at least two chronic conditions but no known cardiovascular disease, discontinuing…

22 hours ago

Ziltivekimab and Pelacarsen Show No Clinical Benefit Despite Effective Biomarker Lowering

Two randomized, placebo-controlled trials of targeted therapies—ziltivekimab, a monoclonal antibody neutralizing interleukin-6, and pelacarsen, an…

2 days ago

Cold Drives Heart Failure Hospitalizations in Older US Adults

Among US Medicare beneficiaries, colder ambient temperatures were associated with increased heart failure hospitalizations while…

6 days ago

No Significant Difference Between Initial CTO-PCI and No CTO-PCI Strategies in 10-Year Follow-Up

In the 10-year extended follow-up of the DECISION-CTO trial, an initial strategy of percutaneous coronary…

6 days ago

This website uses cookies.